This ETF Has Crushed the S&P 500 in 2026. Here's Why I Think It Still Has Room to Grow.

SCHD returned about 23.4% year to date in 2026, versus 15.1% for the S&P 500, and currently has a 3.32% 30-day SEC yield. The article argues that its 102 financially strong, dividend-paying holdings and lower technology exposure—9.2% versus about 40% technology for the S&P 500—could provide relative resilience to higher-for-longer rates or an AI-led sell-off, while noting no ETF is guaranteed to be safe in a bear market. In 2022, SCHD fell about 3%, compared with an 18% decline for the S&P 500 and 32% for the Nasdaq-100.

Analysis

The defensible implication is factor and sector diversification—not immunity to a drawdown. If rates stay high, SCHD’s quality and cash-return tilt could outperform leveraged, long-duration equities, but higher discount rates also pressure dividend-stock valuations and raise the relative appeal of bonds. A payout is not proof of balance-sheet strength: verify current holdings’ leverage, free-cash-flow coverage and dividend growth before treating the yield as defensive. Likewise, lower direct AI exposure reduces concentration risk, but a tech-led selloff can still tighten financial conditions and weaken broad demand; SCHD’s sector mix brings its own exposure to energy cyclicality, healthcare policy and consumer-staples valuation risk.

The recent relative strength may reflect a rotation into value, quality and yield rather than durable excess returns. Near term, positioning and rates can dominate; over 1–3 months, watch real yields, rate expectations and fund flows. Over 6–18 months, sustained earnings and dividend coverage matter more than the headline yield. The contrarian risk is that investors extrapolate recent outperformance and underprice the possibility that falling rates revive growth leadership—or that an inflationary, higher-rate shock hurts defensive equity multiples too. No compelling standalone trade follows without current valuation, holdings and flow data.

Key Decisions for Investors

• Do not chase SCHD solely on recent relative performance or treat its distribution as a bond proxy. Before adding, check current holdings concentration, valuation versus its own history, free-cash-flow dividend coverage and leverage.
• If the portfolio is unusually concentrated in U.S. megacap growth, consider a measured SCHD allocation as a factor/sector diversifier rather than a market-timing hedge. Size it against existing healthcare, staples and energy exposure.
• Watch a conditional relative-value setup: long SCHD versus short SPY only if rate expectations remain elevated and SCHD’s earnings/dividend coverage holds up. Reassess if real yields fall materially and growth leadership broadens, or if SCHD constituents cut guidance or dividends.
• Falsifiers: persistent deterioration in constituent cash-flow coverage, dividend cuts, an energy-led earnings downturn, or a broad risk-off episode in which SCHD fails to defend relative to SPY. Verify current holdings and flows before expressing the trade.